The introduction of novel oral anticoagulants in 2009 has been rightly heralded as a major therapeutic breakthrough.
Professor Emeritus, Department of Cardiology, Medical University of Innsbruck, Anichstraße 35, 6020, Innsbruck, Austria, o.pachinger@i-med.ac.at.
Otmar
O
Pachinger
D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects* / Q000145:classification; D001281:Atrial Fibrillation / Q000150:complications* / Q000188:drug therapy*; D006470:Hemorrhage / Q000139:chemically induced* / Q000517:prevention & control; D006801:Humans; D061214:Patient Safety; D018570:Risk Assessment; D020521:Stroke / Q000209:etiology* / Q000517:prevention & control*
D000925:Anticoagulants